


































Hepatocyte	growth	 factor	 receptor	 substrate	 (HRS)	 is	a	component	of	 the	ESCRT-0	
complex.	 It	 is	 involved	 in	 the	 sorting	 of	 ubiquitylated	 receptors	 into	 the	 lumen	 of	
multivesicular	bodies	(MVBs),	thus	targeting	them	for	lysosomal	degradation.	HRS	is	
highly	 phosphorylated	 in	 response	 to	 stimulation	 by	 various	 growth	 factors,	 but	
despite	this,	the	functional	role	of	its	phosphorylation	is	still	contentious.	Preliminary	
data	 from	our	 laboratory	 suggested	 that	HRS	may	 also	 act	 as	 a	 signalling	 adaptor,	







been	 made,	 its	 EGF	 dependence	 is	 novel.	 DTX3L	 has	 previously	 been	 shown	 to	
modulate	the	recruitment	of	HRS	to	endosomes	in	response	to	stimulation	of	the	G-
protein	coupled	receptor	CXCR4.	This	new	finding	offers	a	theoretical	means	through	





but	 not	 EGF,	 is	 partly	 dependent	 on	 phospho-tyrosine	 residues	 Y329	 and	 Y334.	




Overall,	 my	 thesis	 generates	 new	 tools	 for	 the	 study	 of	 HRS	 function	 and	 for	 the	
analysis	of	endosomal	 signalling.	 I	provide	evidence	 for	 the	 role	of	HRS	 in	RTK	and	
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involved.	 These	 are:	 Caveolae-mediated,	 Flotillin-dependent,	 GRAF1-dependent,	
ArF6-dependent	 and	RhoA-dependent	endocytosis	 (El-Sayed	and	Harashima	2013).	





cells	 could	 internalise	 litmus	 paper	 into	 acidic	 compartments	 (Roth	 2006).	 In	 the	
1930’s	macrophages	were	 imaged	 internalising	extracellular	 fluid,	estimating	that	a	
macrophage	could	internalise	the	equivalent	of	a	third	of	its	own	cell	volume	per	hour.		
Then,	 in	 1964,	 Roth	 and	 Porter	 imaged	 the	 sequence	 of	 events	 that	 lead	 to	 the	
formation	 of	 endocytic	 vesicles	 in	 Aedes	 aegypti	 oocytes	 by	 electron	 microscopy,	
describing	 invagination	 of	 the	 membrane,	 formation	 of	 coated	 pits	 and	 the	
subsequent	pinching	off	of	the	endocytic	vesicle	(Roth	and	Porter	1964).	A	few	years	
later,	the	molecular	coat	on	internalised	vesicles	was	described	as	a	regular	cage-like	





a	 ligand	 to	 the	 assembly	 of	 clathrin	 coated	 pits	 (Anderson,	 Brown	 et	 al.	 1977,	
Anderson,	Goldstein	et	al.	1977,	Goldstein,	Anderson	et	al.	1979).	A	process	that	 is	
now	 known	 as	 receptor-mediated	 endocytosis.	 Later	 this	 form	 of	 endocytosis	was	




















During	 the	1970’s,	extensive	 research	went	 in	 to	 the	study	of	endocytosis,	but	 the	
destination	 of	 internalised	 vesicles	 was	 unclear	 (Roth	 2006).	 Roth	 and	 Porter	
suggested	that	small	vesicles	fuse	to	form	larger	vesicles,	based	on	the	observation	of	






points	 in	MVBs	and	 lysosomes.	A	few	years	 later	 in	1983,	Geuze	et	al.	would	use	a	
double	 labelling	 immunogold	 combined	 with	 cryoEM	 to	 show	 that	 the	










50-80%	 of	 its	 surface	 area	 (Mukherjee,	 Ghosh	 et	 al.	 1997).	 This	 morphology	
encourages	the	recycling	of	receptors	and	the	degradation	of	ligands	(Dunn,	McGraw	
et	al.	1989).	Receptors	and	transmembrane	proteins	are	directed	towards	degradation	
by	 being	 sequestered	 into	 intraluminal	 vesicles	 (ILVs)	 of	 the	 maturing	 endosome,	






to	 their	 distinctive	 morphology	 (Sotelo	 and	 Porter	 1959).	 MVBs	 contain	 small	
intraluminal	 vesicles	 which	 form	 from	 the	 limiting	 membrane	 of	 the	 maturing	
endosome.	 Studies	 from	Stanley	Cohen	and	 colleagues	 in	 the	 late	1970’s	 followed	
ferritin-conjugated	EGF	which	had	been	internalised.	They	show	that	this	tagged	EGF	
passes	 through	 MVBs	 en	 route	 to	 the	 lysosome	 (Gorden,	 Carpentier	 et	 al.	 1978,	
Haigler,	McKanna	et	al.	1979).	In	the	following	decade	it	was	shown	that	the	EGFR	was	
sorted	with	EGF	into	the	lumen	of	MVBs	(Miller,	Beardmore	et	al.	1986).	It	was	not	





























the	 retromer	 and	WASH	 complex.	 Alternatively,	 the	 receptor	 can	 be	 sorted	 for	
degradation	 through	 interaction	 with	 the	 ESCRT	 machinery,	 leading	 to	
internalisation	 into	 the	 lumen	 of	 the	 endosome	 and	 the	 formation	 of	 the	











YOTB,	 Vac1	 and	 EEA1)	 domain	 containing	 proteins	 to	 early	 endosomes	 (Gillooly,	
Simonsen	et	al.	2001).	The	most	widely	used	protein	marker	of	early	endosomes	is	the	
Rab5	effector,	EEA1.	EEA1	is	recruited	to	early	endosomes	by	the	dual	interaction	with	







Rab	species	on	 the	 recycling	endosome	 is	Rab11	 (Ullrich,	Reinsch	et	al.	1996).	The	
function	of	Rab21	is	less	well	understood	but	has	been	shown	to	be	involved	in	the	







as	markers	 for	 the	 late	 endosome	when	used	 in	 conjunction	with	 the	mannose	6-































fraction	 consisting	 of	 smaller	 granules	 termed	 microsomes.	 By	 adjusting	 the	



















positive	 compartments	 had	 also	 been	 identified	 to	 contain	 mitochondria.	 These	
compartments	could	be	induced	by	stimulation	with	glucagon	and	along	with	careful	





a	 double	 membraned	 organelle	 called	 the	 autophagosome,	 which	 at	 this	 point	 is	





Despite	 the	 term	 ‘autophagy’	 being	 coined	 in	 1963,	 the	 proteins	 responsible	 for	
autophagy	were	not	identified	until	the	1990’s	(Ohsumi	2014).	A	genetic	Yeast	screen	
by	Yoshinori	Ohsumi	would	determine	a	 series	of	 genes	 involved	 in	 the	process	of	
autophagy.	 Now	 termed	 autophagy-related	 (Atg)	 genes,	 almost	 all	 of	 the	










that	 reticulocytes,	 which	 do	 not	 contain	 lysosomes,	 are	 able	 to	 rapidly	 degrade	
abnormal	 haemoglobin	 (Rabinovitz	 and	 Fisher	 1964).	 Disruption	 of	 lysosomal	
degradation	 by	 treatment	 with	 chloroquine	 effectively	 abolishes	 degradation	 of	
extracellular	proteins,	but	had	no	effect	on	the	degradation	of	short-lived	intracellular	
proteins	(Poole,	Ohkuma	et	al.	1977).	It	was	not	until	1977,	more	than	two	decades	
after	 the	 initial	 identification	 of	 the	 lysosome,	 that	 an	 ATP-dependent	 protein	
degradation	 pathway	 separate	 from	 the	 lysosome	 was	 discovered	 (Etlinger	 and	
Goldberg	1977).	This	work	was	carried	out	in	Reticulocyte	lysates	and	in	an	attempt	to	
identify	the	components	of	the	new	degradative	system	led	to	the	 identification	of	
ATP-dependent	 proteolysis	 factor-1	 (APF-1),	 an	 8,500Da	 peptide	 that	 is	 covalently	
attached	to	target	substrates	via	an	isopeptide	bond	(Ciechanover,	Hod	et	al.	1978).	
Around	 the	 same	 time,	 ubiquitin	 was	 characterised	 as	 a	 post-translational	
modification	of	the	side	chain	of	lysine	residues	on	Histone	2A	(Goldknopf	and	Busch	





Soon	 after	 the	 rest	 of	 the	 components	 of	 the	 ubiquitin	 conjugating	 pathway	were	
deciphered.	 The	 pathway	 consists	 of	 a	 cascade	 of	 three	 enzymes	 leading	 to	 the	
addition	of	ubiquitin	to	the	target	substrate	(Hershko,	Heller	et	al.	1983).	The	first	class	
of	enzymes	 in	 this	cascade	 is	 the	ubiquitin-activating	enzyme	 (E1),	 followed	by	 the	
ubiquitin-carrier	 protein	 (E2)	 and	 finally	 the	 ubiquitin-protein	 ligase	 (E3).	 The	 E1	








system,	 falling	 into	 these	 three	 categories	 of	 enzymes	 and	 along	 with	 a	 class	 of	









For	 the	 next	 decade	 after	 the	 discovery	 of	 the	 proteasome,	 it	 was	 believed	 that	
ubiquitin	was	primarily	the	signal	 for	degradation	via	the	proteasome.	 In	1998,	the	










transmembrane	 proteins	 to	 be	 degraded	 via	 the	 lysosome.	 The	 yeast	 G-protein	
coupled	receptor	(GPCR),	Ste2,	activates	the	mitogen-activated	protein	(MAP)	kinase	
pathway	in	response	to	stimulation	with	a	peptide	hormone,	α-factor	(Terrell,	Shih	et	
al.	 1998).	 This	 receptor	 is	 sorted	 into	 the	 lumen	 of	 MVBs	 en-route	 to	 vacuole	
degradation;	however,	mutation	of	the	lysine	residues	within	its	cytoplasmic	domain	
prevents	 the	down	regulation	of	 this	 receptor.	Further	evidence	 that	ubiquitin	can	
target	proteins	for	lysosomal	degradation	came	when	ubiquitin	was	fused	to	a	stable	




straightforward	 (Katzmann,	 Odorizzi	 et	 al.	 2002).	 The	 ubiquitin-ATPase	 chimera	
mentioned	above	suggests	that	ubiquitin	acts	as	a	signal	for	internalisation.	This	idea	
is	 supported	 by	 a	 reduced	 uptake	 of	 the	 Ste2	 lysine	 mutant.	 For	 other	 proteins	
however,	 internalisation	 is	not	affected	by	defects	 in	 their	ubiquitylation.	 Ste6	and	
Fur4,	 for	 example,	 accumulate	 in	 pre-vacuolar	 compartments	 instead	 of	 being	





















new	 site	 that	 other	 proteins	 can	 interact	with.	 In	 order	 to	 interact	with	 ubiquitin,	





The	 sequence	 of	 this	 motif	 was	 subsequently	 used	 in	 a	 bioinformatics	 search	 to	
identify	 other	 ubiquitin	 binding	 proteins	 (Hofmann	 and	 Falquet	 2001).	 Yeast	 two	





UBDs	 can	 be	 found	 on	 many	 endosomal	 proteins.	 Since	 ubiquitin	 is	 a	 signal	 for	
lysosomal	degradation,	components	of	the	endosomal	sorting	machinery	require	the	










of	 MVBs,	 appropriate	 trafficking	 of	 membrane	 proteins	 to	 the	 lysosome	 and	
attenuation	of	receptor	signalling	like	growth	factor	signalling	pathways	(Figure	1.3).	






CUE	 α-Helix	 Vps9	 	(Prag,	Misra	et	al.	2003)	
dUIM	 α-Helix	 HRS	 	(Hirano,	Kawasaki	et	al.	2006)	
GAT	 α-Helix	 GGA3,	TOM1	 	(Akutsu,	Kawasaki	et	al.	2005)	
GLUE	 PH	domain	 EAP45	 	(Slagsvold,	Aasland	et	al.	2005)	
IUIM	 α-Helix	 RABEX5	 	(Lee,	Tsai	et	al.	2006)	
Jab1/MPN	 Other	 Prp8	 	(Bellare,	Small	et	al.	2008)	
NZF	 Zinc	Finger	(ZnF)	 Vps36	 	(Alam,	Sun	et	al.	2004)	
PAZ	 Zinc	Finger	(ZnF)	 USP5	 	(Reyes-Turcu,	Horton	et	al.	2006)	
PFU	 Other	 Doa1	 	(Fu,	Zhou	et	al.	2009)	
PRU	 PH	domain	 RPN13	 	(Schreiner,	Chen	et	al.	2008)	
SH3	 Other	 Sla1	 	(Stamenova,	French	et	al.	2007)	
UBA	 α-Helix	 NBR1	 	(Kirkin,	Lamark	et	al.	2009)	
UBAN	 α-Helix	 NEMO	 	(Rahighi,	Ikeda	et	al.	2009)	
UBC	 Ubc-like	domain	 UBCH5	 	(Brzovic,	Lissounov	et	al.	2006)	
UBM	 α-Helix	 Polymerase	iota	 	(Bienko,	Green	et	al.	2005)	
UBZ	 Zinc	Finger	(ZnF)	 Polymerase-h	 	(Bienko,	Green	et	al.	2005)	
UEV	 Ubc-like	domain	 TSG101	 	(Sundquist,	Schubert	et	al.	2004)	
UIM	 α-Helix	 S5a/Rpn10,	STAM	 	(Terrell,	Shih	et	al.	1998)	
VHS	 α-Helix	 STAM,	HRS	 	(Mizuno,	Kawahata	et	al.	2003)	










These	 Vps	 mutants	 can	 be	 further	 characterised	 in	 to	 classes	 depending	 on	 the	
morphological	defect.	All	components	of	the	ESCRT	machinery	are	classified	as	‘Class	
E’	 Vps	 mutants,	 which	 are	 defined	 by	 enlarged	 endosomes	 (Raymond,	 Howald-
Stevenson	et	al.	1992).	Membrane	proteins	were	shown	to	traffic	to	the	vacuole	via	
MVBs	 through	 studies	 with	 carboxypeptidase	 S	 (CPS)	 (Odorizzi,	 Babst	 et	 al.	 1998,	
Reggiori	and	Pelham	2001).	Further	studies	with	a	chimera	protein	of	CPS	and	His3	
would	 establish	 that	 the	 enlarged	 endosomes	 seen	 in	 class	 E	 mutants	 is	 due	 to	
defective	 sorting	 into	 the	 endosomal	 lumen	 (Odorizzi,	 Katzmann	 et	 al.	 2003,	
Katzmann,	Sarkar	et	al.	2004).		
	
Figure	 1.3	 Overview	 of	 the	 ESCRT	 machinery.	 Ubiquitylated	 receptors	 at	 the	
endosome	are	recognised	by	the	ESCRT-0	complex	comprised	of	HRS	and	STAM.	As	
this	 complex	 can	 bind	 to	multiple	 ubiquitin	molecules,	 it	 corrals	 receptors	 into	
clathrin	 coated	 microdomains	 before	 passing	 the	 receptor	 on	 to	 the	 ESCRT-I	
complex.	 This	 in	 turn	 passes	 the	 receptors	 on	 the	 ESCRT-II,	 which	 also	 recruits	
ESCRT-III.	 The	 ESCRT-III	 complex	 is	 responsible	 for	 the	 invagination	 of	 the	






































as	a	 subunit	 a	 few	years	 later	 (Bishop	and	Woodman	2001,	Bache,	 Slagsvold	et	al.	

















































consisting	 of	 Hepatocyte	 growth	 factor	 receptor	 substrate	 (HRS)	 and	 Signal	










is	 the	 first	 point	 of	 contact	 a	 ubiquitylated	 receptor	 will	 have	 with	 the	 ESCRT	
machinery	and	is	essential	for	the	initiation	of	the	ESCRT	pathway	at	endosomes	and	
the	 formation	 of	MVBs.	 ESCRT-0	 is	 also	 required	 for	MVB	 formation	 in	Drosophila	
melanogaster,	mice	and	yeast,	 indicating	that	 its	role	 is	conserved	among	different	
species	(Raymond,	Howald-Stevenson	et	al.	1992,	Komada	and	Soriano	1999,	Lloyd,	









(HGF)	 receptor	 (Komada	 and	 Kitamura	 1995).	 HRS	 is	 recruited	 to	 endosomal	
membranes	via	its	FYVE	domain,	which	interacts	with	PtdIns(3)P	(Gaullier,	Simonsen	
et	al.	1998,	Raiborg,	Bremnes	et	al.	2001).	HRS	also	contains	a	double	sided	ubiquitin	
interacting	motif	 (UIM),	as	well	 as	a	VHS	domain	 that	 is	also	capable	of	binding	 to	
ubiquitin,	 Golgi-localised,	 γ-adaptin	 ear	 homology	 domain	 (GGA)	 proteins	 interact	
with	 ubiquitin	 via	 VHS	 domains	 (Bilodeau,	 Urbanowski	 et	 al.	 2002).	 Though	 these	
domains	only	weakly	bind	 to	ubiquitin,	 they	 allow	HRS	 to	 gather	 the	ubiquitylated	














the	 membrane	 binding	 dynamics	 of	 HRS.	 When	 stimulated	 with	 a	 growth	 factor,	
phosphorylated	HRS	 is	 predominantly	 present	 in	 the	 cytosol,	 despite	 the	 fact	 that	
endocytosis	 of	 growth	 factor	 receptors	 to	 the	 endosome	 is	 required	 for	 this	
phosphorylation	 in	 the	 first	 place	 (Urbé,	 Mills	 et	 al.	 2000).	 It	 could	 be	 that	









domains	 of	HRS	 (Figure	 1.5),	 and	 that	many	 of	 these	 sites	 have	 been	more	 highly	
observed	than	those	sites	 found	within	the	functional	domains	 (Urbé,	Sachse	et	al.	





Figure	 1.4	 Schematic	 diagram	 of	 HRS	 at	 endosomes.	 HRS	 is	 recruited	 to	 early	
endosomes	 through	 the	 interaction	 between	 its	 FYVE	 domain	 and	 PtdIns(3)P,	
where	 it	 forms	 the	 ESCRT-0	 complex	 with	 STAM.	 HRS	 can	 interact	 with	











sorting	 ubiquitylated	 receptors	 into	 newly	 forming	 ILVs,	 thus	 targeting	 cargo	 for	
lysosomal	 degradation,	 it	 comes	 as	 no	 surprise	 that	 HRS	 has	 been	 shown	 to	 be	

















studies	 examining	 the	 outward	 budding	 of	 HIV.	 Subsequent	 studies	 have	
demonstrated	 the	 involvement	 of	 HRS	 in	 the	 normal	 functioning	 of	 the	 immune	
system.	In	2011,	HRS	was	shown	to	actually	inhibit	HIV-1	virion	production	(Ding,	Su	
et	al.	2011).	This	effect	is	mediated	through	its	interaction	with	citron	kinase	via	its	
FYVE	 domain.	 Depletion	 of	 HRS	 led	 to	 increased	 virion	 production.	 Sorting	 of	 the	
	 21	
interleukin	receptor	(IL2)	has	also	been	shown	to	be	mediated	by	HRS,	in	a	manner	
that	 is	 independent	of	 its	ubiquitin	binding	(Yamashita,	Kojima	et	al.	2008).	A	study	
from	 Nagata	 et	 al.	 in	 2014	 provided	 evidence	 for	 the	 importance	 of	 HRS	 in	 the	
development	of	peripheral	B	lymphocytes	and	in	the	T-cell	dependent	production	of	
antibodies	 (Nagata,	 Murata	 et	 al.	 2014).	 In	 patients	 infected	 with	 Enterovirus	 71	
(EV71),	it	was	found	that	HRS	had	been	upregulated	and	is	an	important	regulatory	of	









pyramidal	 neurons	 (Tamai,	 Toyoshima	 et	 al.	 2008).	 HRS	 was	 further	 shown	 to	 be	
important	 for	the	normal	recycling	of	 full	 length	TrkB	receptor,	another	 interaction	
not	dependent	on	the	UIM	of	HRS	(Huang,	Zhao	et	al.	2009).	In	2016,	loss	of	HRS	was	
shown	 to	 lead	 to	 the	 disruption	 of	 the	 autophagic	 degradation	 of	 disease-related	
proteins,	such	as	Huntingtin.	This	leads	to	ER-stress	and	both	apoptosis	and	necrotopic	
cell	death	in	hippocampal	neuronal	cells	(Oshima,	Hasegawa	et	al.	2016).		Watson	et	
al.	 showed	 that	 neuronal	 deficits	 in	 teetering	 mice	 were	 a	 result	 of	 spontaneous	
mutation	 to	HRS.	 They	 show	 that	HRS	plays	 a	 role	 in	 the	maintenance	of	 synaptic	
transmission	and	that	the	expression	of	HRS	in	the	nervous	systems	is	developmentally	
regulated	(Watson,	Bhattacharyya	et	al.	2015).	Further	examples	demonstrating	the	
importance	 of	 HRS	 in	 development	 highlight	 the	 role	 it	 plays	 in	 developmental	



























































Recycling	 of	 internalised	 cell	 surface	 proteins	 is	 important	 to	maintain	 the	 cellular	
pool.	When	the	sorting	endosome	was	first	described,	termed	CURL	(compartment	for	




















an	 integral	 component	 of	 the	 endosomal	 recycling	machinery	 (Seaman	2012).	 The	
complex	 is	 comprised	 of	 5	 proteins,	 Vps35p,	 Vps29p,	 Vps26p,	 Vps5p	 and	 Vps17p	
(Horazdovsky,	 Davies	 et	 al.	 1997,	 Seaman,	 Marcusson	 et	 al.	 1997).	 The	 retromer	
mediates	many	elements	of	transport	from	the	endosome	and	is	implicated	in	many	











that	 transiently	 interact	 with	 each	 other.	 Particularly	 when	 you	 consider	 that	 the	
traditional	 pentamer	 is	 not	 as	 stable	 in	 mammalian	 cells	 as	 was	 seen	 in	 yeast	
(Swarbrick,	 Shaw	et	 al.	 2011).	 The	 retromer	 can	 therefore	 be	 divided	 into	 a	 cargo	
selective	trimer	consisting	of	Vps35p,	Vps29p	and	Vps26p;	and	a	dimer	made	from	the	
dimerization	 of	 the	 Sorting	 nexin	 (Snx)	 family	 members,	 Vps5p	 and	 VPS17p	
(Horazdovsky,	 Davies	 et	 al.	 1997,	Nothwehr	 and	Hindes	 1997).	 These	 proteins	 are	
often	 described	 as	 Snx-BAR	 proteins	 to	 differentiate	 them	 from	 other	 Snx	 family	

















Recruitment	 of	 the	 Snx-BAR	 dimers	 to	 membranes	 occurs	 through	 their	 Phox	
homology	(PX)	domains,	common	amongst	the	Snx	family	of	proteins	(Cozier,	Carlton	





shown	 in	 amoeba	 (Nakada-Tsukui,	 Saito-Nakano	 et	 al.	 2005).	 Interestingly,	 the	
retromer	CSC	requires	both	Snx3	and	Rab7a	for	efficient	recruitment	to	endosomes,	
suggesting	that	 the	recruitment	of	 the	whole	complex	 is	 temporally	controlled	and	
occurs	 during	 the	 Rab5/7	 switch	 of	 the	maturing	 endosome	 (Harterink,	 Port	 et	 al.	
2011).	Further	regulation	of	the	retromer	CSC	is	also	evident	from	the	fact	that	Rab7a	
is	also	present	on	lysosomes	but	the	CSC	is	not.	Moreover,	proteins	implicated	in	the	
regulation	 of	 Rab7a	 activity	 will	 also	 be	 indirectly	 involved	 in	 the	 regulation	 of	
retromer	 CSC	 recruitment.	 TBC1D5,	 a	 Rab-GAP	 that	 can	 displace	 the	 CSC	 from	
endosomes	 if	overexpressed	(Seaman,	Harbour	et	al.	2009).	Whereas,	mutations	 in	














(Shi,	 Rojas	 et	 al.	 2006).	 Furthermore,	 CIMPR	 requires	 Vps26a	 for	 appropriate	
endosomal	 sorting,	 but	 does	 not	 require	 Vps26b	 (Bugarcic,	 Zhe	 et	 al.	 2011).	 In	
conjunction	 with	 this,	 although	 early	 studies	 indicated	 that	 cargo	 sorting	 by	 the	
retromer	required	both	the	CSC	timer	and	the	Snx-BAR	dimer,	instances	where	this	






In	 2017,	 a	 second	 complex,	 which	 is	 functionally	 similar	 to	 the	 retromer,	 was	














































endosomes.	 These	 domains	 help	 to	 sort	 actin-binding	 domain	 (ABD)	 containing	







for	 its	 interactions	 with	 Wash1	 and	 KIAA1033,	 and	 an	 unstructured	 tail.	 The	
unstructured	tail	alone	is	enough	to	localise	Fam21	to	membranes.	The	tail	contains	
multiple	 Leu-Phe	and	acidic	 residue	 repeated	motifs	 (LFa	motifs)	 (Jia,	Gomez	et	al.	
2012).	Through	these	repeated	motifs	it	is	believed	that	Fam21	binds	to	Vps35,	with	
the	more	distal	repeats	being	more	important	for	this	interaction	than	the	proximal	
repeats.	 In	vivo,	Fam21	will	only	 interact	with	Vps35	 if	 it	 is	 in	complex	with	Vps29,	










the	 recycling	 of	 certain	 proteins	 back	 to	 the	 PM,	 e.g.	 the	 EGFR,	 Glut-1	 and	 CD28.	





Much	 like	 other	 members	 of	 the	WASP	 complex	 superfamily,	WASH	 is	 inherently	
inactive	by	itself.	The	activity	of	this	complex	is	regulated	by	the	E3	ubiquitin	 ligase	
TRIM27.	Moreover,	the	activity	of	this	enzyme	is	increased	by	another	protein	called	















Golgi	or	 recycled	back	 to	 the	PM	 is	 regulated.	Current	opinion	believes	 that	 this	 is	
achieved	via	associated	proteins	to	the	complex,	such	as	Snx27	(Temkin,	Lauffer	et	al.	
2011).	 Further	 to	 this,	 the	WASH	 complex	 has	 also	 been	 associated	 with	 BLOC-1	
(biogenesis	 of	 lysosomal-related	 organelles	 complex	 1)	 and	 may	 be	 involved	 with	









disorders.	 Mutations	 in	 strumpellin,	 for	 example,	 can	 lead	 to	 Hereditary	 spastic	














this	 period.	 Levi-Montalcini	 showed	 that	 a	 mouse	 sarcoma	 had	 an	 impact	 on	 the	
growth	of	a	 chick	embryo’s	nervous	 system	 (Levi-Montalcini	 and	Hamburger	1951,	
Levi-Montalcini	1952,	Levi-Montalcini,	Meyer	et	al.	1954).	A	few	years	later,	the	factor	
responsible	for	this	observation	was	isolated	from	mouse	sarcomas	and	then	isolated	




(EGF)	by	Cohen	 in	 the	1960’s.	Extracts	 from	mice	submaxillary	glands	could	 induce	







bind	 to	 fibroblasts	 before	 being	 degraded	 by	 the	 cells	 (Carpenter,	 Lembach	 et	 al.	
1975).	By	the	end	of	the	decade,	EGF	had	been	shown	to	induce	phosphorylation	of	
endogenous	 proteins	 in	 A-432	 tumour	 cells,	 providing	 insights	 into	 the	 molecular	
mechanisms	by	which	cells	would	translate	the	growth	factor	signal	into	a	biological	
response	 (Carpenter,	King	et	al.	1978).	The	 receptor	 for	EGF	 (EGFR,	also	known	as	
ErbB1)	 wasn’t	 fully	 sequenced	 until	 1984	 (Ullrich,	 Coussens	 et	 al.	 1984).	 Other	
members	of	the	EGF	receptor	family	(ErbB2-4)	would	be	identified	over	the	next	few	







conserved	 from	C.	 elegans	 to	 humans	 (Lemmon	 and	 Schlessinger	 2010).	With	 the	
















Whereas	 with	 the	 EGFR,	 ligand	 binding	 results	 in	 a	 conformational	 change	 in	 the	
extracellular	portion	of	the	receptor.	This	leads	to	the	region	that	is	responsible	for	










tyrosine	 kinase	 domain	 (TKD)	 can	 occur,	 leading	 to	 downstream	 signalling	 events	
(Honegger,	Kris	et	al.	1989).	
	
Auto-phosphorylation	of	RTKs	occurs	 in	distinct	phases.	The	first	of	 these	phases	 is	
responsible	for	relieving	the	auto-inhibition	placed	on	the	receptor	and	increasing	the	
kinase	 activity	 of	 the	 intrinsic	 TKD	 (Lemmon	 and	 Schlessinger	 2010).	 Despite	 the	
inactive	form	of	TKDs	varying	substantially	between	different	RTKs	,	the	active	form	of	
these	domains	 is	actually	very	similar	 (Huse	and	Kuriyan	2002).	This	 is	because	key	
regulatory	components	of	TKDs	need	to	adopt	a	specific	configuration	in	order	to	allow	
for	 efficient	 transfer	 of	 phosphate	 groups,	 and	 therefore,	 increased	 kinase	 activity	













phosphorylation	of	 the	 TKD	 can	 lead	 to	 greater	 increases	 in	 its	 kinase	 activity.	 For	














active	 conformation	 (Boyer,	 Turchi	 et	 al.	 2006,	 Qiu,	 Tarrant	 et	 al.	 2008).	 The	





The	 second	 phase	 of	 auto-phosphorylation	 is	 responsible	 for	 creating	 phospho-





binding	 (PTB)	 domain	 containing	 signalling	 adaptors	 (Mohammadi,	Honegger	 et	 al.	
1991,	 Pawson	 2004).	 These	 proteins	 are	 recruited	 either	 directly	 to	 the	 RTK	 or	 to	
already	docked	accessory	proteins,	e.g.	 insulin	 receptor	substrate	1	 (IRS1)	with	 the	
insulin	 receptor	 that	 becomes	hyper-phosphorylated	 in	 response	 to	RTK	 activation	
(Sun,	Crimmins	et	al.	1993).	From	here,	the	RTK	can	activate	a	number	of	signalling	
pathways,	 such	 as	 the	MAPK	or	 Akt	 signalling	 pathways.	 Although	 these	 pathways	














cancer	 (NSCLC),	 breast,	 pancreatic,	 ovarian,	 head	 and	 neck,	 etc.	 (Arteaga	 and	









domain	 is	 cleaved	 and	 translocates	 to	 the	 nucleus	 in	 order	 to	 regulate	 gene	







and	 subsequently	 redistributed	 to	 internal	 compartments	within	 the	 cells	 (Haigler,	
McKanna	 et	 al.	 1979).	 Endocytosis	 in	 turn,	 became	 viewed	 as	 a	 down	 regulatory	
mechanism,	by	which	the	cell	could	attenuate	growth	factor	signals	in	order	to	prevent	











converging	 signalling	 pathways.	 Separation	 of	 plasma	 membrane	 and	 endosomal	
compartments	 after	 stimulation	 with	 either	 EGF	 or	 insulin,	 showed	 greater	
internalisation	of	 the	EGFR	compared	 to	 the	 insulin	 receptor,	and	greater	 levels	of	
tyrosine	 phosphorylation	 in	 endosomal	 compartments	 when	 stimulated	 with	 EGF,	
compared	 to	 stimulation	 with	 insulin	 (Di	 Guglielmo,	 Baass	 et	 al.	 1994).	 These	










be	 removed	 from	 the	 cell	 surface	 with	 the	 addition	 of	 glutathione,	 while	 the	
internalised	antibody	would	retain	its	tag	(Burke,	Schooler	et	al.	2001).	This	allowed	
them	to	analyse	the	differences	in	signalling	within	the	normal	physiological	context	














Wang,	 Pennock	 et	 al.	 2004).	 These	 studies	 show	 that	 signal	 transduction	 can	 be	











dynamin	 inhibition.	 This	 study	 also	 showed	 that	 phosphorylation	 of	 the	 ESCRT-0	
complex	 by	 EGF	 is	 highly	 dependent	 on	 endocytosis.	 The	 studies	 described	 above	
introduce	the	concept	of	spatial	regulation	of	RTKs,	whereby,	signals	generated	at	the	











share	 a	 7	 transmembrane	 (7TM)	 structure	 and	 are	 linked	 to	 second	 messenger	
generating	enzymes	via	the	action	of	heterotrimeric	G-proteins	(Gilman	1987).	Much	
of	 what	 we	 know	 about	 these	 receptors	 was	 pioneered	 by	 research	 into	 the	 β-
adrenergic	 receptor.	 This	work	 done	 in	 the	 1970’s	 and	 1980’s	 by	 Lefkowitz	would	
ultimately	 lead	 him	 to	 win	 the	 Nobel	 Prize	 in	 chemistry	 in	 2012	 for	 his	 efforts	
(Lefkowitz	2007).			
	
Figure	1.7	Spatial	 regulation	of	Receptor	tyrosine	kinases	 (RTKs).	The	receptor	 is	
activated	 at	 the	 plasma	membrane,	 where	 it	 exposed	 to	 an	 array	 of	 signalling	






was	 even	 an	 individual	molecule	 (Lefkowitz	 2007).	 The	 biochemist	 Earl	 Sutherland	
even	said	at	the	time	that	it	was	possible	the	β-adrenergic	receptor	could	be	a	binding	
site	 on	 Adenylate	 cyclase	 (AC)	 (Robison,	 Butcher	 et	 al.	 1967).	 In	 the	 early-to-mid	
1970’s	radio-ligands	were	generated	for	the	β-	and	α-adrenergic	receptor	(Mukherjee,	
Caron	et	al.	1975),	as	well	as	for	a	number	of	other	receptors	such	as	glucagon,	opioid	
and	 muscarinic	 cholinergic	 receptors	 (Rodbell,	 Birnbaumer	 et	 al.	 1971,	 Pert	 and	
Snyder	 1973,	 Yamamura	 and	 Snyder	 1974).	 These	 tools	 helped	 to	 build	 on	 our	
understanding	 of	 the	 physiological	 outputs	 governed	 by	 the	 receptors	 they	 were	







finally	 accepted	 as	 a	 receptor.	 Reconstitution	 of	 the	 β-adrenergic	 receptor	 into	
xenopus	 erythrocytes	 allowed	 the	 previously	 unresponsive	 cells	 to	 respond	 to	
catecholamines	(Cerione,	Strulovici	et	al.	1983).	A	year	later	this	experiment	was	taken	








to	 light	 sensitive	 proteins	 (Ovchinnikov	 Yu	 1982).	 Further	 sequencing	 of	 the	 other	
adrenergic	 receptors	 strengthened	 this	 argument	 (Kobilka,	 Matsui	 et	 al.	 1987,	
Dohlman,	Thorner	et	al.	1991).	Over	the	next	few	years	the	7TM	class	of	receptors	
began	 to	 grow	 rapidly	 as	 more	 receptors	 were	 cloned,	 including	 the	 muscarinic	
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The	α2-	and	β2-	adrenergic	 receptors	are	an	 interesting	pair	of	 receptors	and	 their	
study	 has	 given	 great	 insight	 into	 the	 structural	 function	 of	 GPCRs.	 These	 two	
receptors	 share	a	 reasonably	high	degree	of	 sequence	homology,	and	 interestingly	
both	bind	the	same	adrenergic	ligands,	but	with	opposite	downstream	effects.	While	
the	β2	receptor	will	increase	the	activity	of	AC,	the	α2	receptor	will,	in	contrast,	inhibit	
AC	activity	due	 to	 the	binding	of	Gs	and	Gi	 respectively.	A	 series	of	 chimeras	were	
generated	 in	order	 to	determine	which	 regions	of	 the	 receptor	would	 translate	 to	
which	 function	 and	where	 specificity	 for	G-proteins	 could	 be	 determined	 (Kobilka,	
Kobilka	et	al.	1988).	From	these	experiments	performed	in	the	late	1980’s	and	early	
1990’s,	it	was	determined	that	the	third	intracellular	loop	was	responsible	for	Gs	and	
Gi	 specificity,	 while	 ligand	 binding	 was	 determined	 by	 the	 membrane	 spanning	
domains	(Ostrowski,	Kjelsberg	et	al.	1992).	It	was	also	shown	that	residues	in	the	distal	












translational	modification	 (PTM)	such	as	phosphorylation.	This	was	 later	 confirmed	




been	 renamed	 GRK2	 (Benovic,	 Strasser	 et	 al.	 1986).	 This	 enzyme	 appeared	 to	 be	
similar	 to	 an	 enzyme	 identified	 in	 rod	 cells,	 which	 was	 responsible	 for	 the	

















phosphodiesterase’s	 to	 increase	 the	 rate	 of	 cAMP	degradation	 (Perry,	 Baillie	 et	 al.	
2002).	Arrestins	can	also	act	as	adaptors	 for	proteins	 involved	 in	clathrin	mediated	
endocytosis	 in	 order	 to	 aid	 in	 the	 internalization	 of	 activated	 GPCRs	 (Ferguson,	
Menard	 et	 al.	 1995,	 Laporte,	 Oakley	 et	 al.	 1999).	 Once	 internalized	 to	 endosomal	
















from	 study	 of	 Ste2	 in	 2006.	 When	 activated,	 Ste2	 catalyzes	 guanine	 nucleotide	
exchange	of	the	Gα	subunit,	allowing	the	βγ	subunits	to	dissociate	and	transduce	the	







thyroid-stimulating	 hormone	 (TSH)	 receptor	 show	 that	 receptor	 activity	 is	 poorly	
reversed	after	the	hormone	is	washed	out	(Calebiro,	Nikolaev	et	al.	2009).	However,	
upon	inhibition	of	endocytosis	with	the	dynamin	inhibitor,	Dynasore,	they	were	able	
to	 attenuate	 the	 persistent	 signal	 with	 removal	 of	 the	 TSH.	 Interestingly,	 this	
persistent	signal	produced	by	the	TSHR	continues	after	TSH	has	dissociated	from	the	














from	 the	 βγ	 subunits	 and	 activates	 various	 effectors.	 The	 GPCR	 is	 then	













Sustained	 cAMP	 signalling	 had	 previously	 been	 ruled	 out	 for	 the	 β-adrenergic	
receptor,	 however,	 in	 2013,	 an	 elegant	 study	 using	 conformational	 biosensors	 of	
active	G-proteins	found	that	isoproterenol	was	able	to	induce	endosomally	active	G-



















In	 1999,	 it	 was	 suggested	 that	 GPCR	 stimulation	 led	 to	 the	 activation	 of	
metalloproteinases	 and	 cleavage	 of,	 for	 example,	 heparin-binding	 EGF	 (HB-EGF)	
(Prenzel,	 Zwick	et	 al.	 1999).	 Further	examples	of	metalloproteinase	 involvement	 in	
GPCR-RTK	crosstalk	were	observed	over	the	next	few	years	in	cardiac	cells	with	the	
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angiotensin	 receptors,	and	 in	 response	 to	other	 factors	 such	as	Helicobactor	pylori	
infection	 (Uchiyama-Tanaka,	Matsubara	 et	 al.	 2001,	 Asakura,	 Kitakaze	 et	 al.	 2002,	
Wallasch,	 Crabtree	 et	 al.	 2002).	 This	 gave	 rise	 to	 the	 ‘triple	 membrane	 passing	
signalling’	 (TMPS)	model,	whereby	 the	 signal	 crosses	 the	 plasma	membrane	 three	
times.	Other	mechanisms	for	the	transactivation	of	RTKs	have	also	been	suggested.	
Src	 and	 Pyk	 were	 shown	 to	 interact	 with	 the	 EGFR	 in	 response	 to	 LPA	 receptor	
activation	(Luttrell,	Hawes	et	al.	1996,	Keely,	Calandrella	et	al.	2000).	Src	is	capable	of	
directly	 phsophorylating	 the	 EGFR	 (Biscardi,	 Maa	 et	 al.	 1999).	 Another	 possible	

























A	 major	 aim	 of	 the	 work	 described	 in	 this	 thesis	 is	 to	 expand	 upon	 our	 current	
knowledge	 surrounding	 the	 role	 of	 HRS	 in	 endosomal	 signalling	 and	 trafficking.	 In	
particular,	 I	 hoped	 to	 advance	 our	 understanding	 of	 the	 function	 of	 HRS	
phosphorylation.	HRS	is	a	prominent	target	of	RTK	activity,	but	despite	this,	the	role	
of	 HRS	 phosphorylation	 is	 still	 up	 for	 contention.	 Furthermore,	 the	 profile	 of	 HRS	
phsophorylation	changes	when	stimulating	with	different	growth	factors	(Row,	Clague	







by	 mass	 spectrometry	 and	 to	 also	 establish	 proximity	 labelling	 techniques	 in	 the	
laboratory.	Secondly,	 I	aimed	to	build	upon	the	existing	tools	and	methodologies	in	






There	 is	 evidence	 that	 suggests	 phosphorylation	 of	 HRS	 may	 alter	 its	 binding	
properties	with	membranes	(Urbé,	Mills	et	al.	2000).	I	therefore	aimed	to	visualise	the	
dynamics	of	HRS	recruitment	to	endosomes	in	response	to	growth	factor	stimulation.	
Tyrosine	 residues	 329	 and	 334	 of	 HRS	 have	 been	 identified	 as	 principal	










Dulbecco’s	 Modified	 Eagle’s	 Medium	 (DMEM)	 +	 GlutaMAX-I	 (#31966-021),	 Fetal	
bovine	serum	(FBS)	(#10270),	Penicillin	and	Streptomycin	antibiotic	mixture	(#15140-
122)	 and	 Minimum	 Essential	 Medium/Non-Essential	 Amino	 Acids	 (MEM/NEAA)	
(#11140-035)	were	purchased	from	Thermo	Fisher	Scientific.	Trypsin-EDTA	(#15400)	
and	 Opti-MEM	 (#409864),	 and	 Hygromycin	 B	 (#10687010)	 were	 from	 Invitrogen	
(Paisley,	UK).	GeneJuice®	Transfection	reagent	(#70967-3)	came	from	EMD	Millipore	
(Darmstadt,	Germany).	Geneticin	(G418)	(#04727878001)	was	purchased	from	Roche	
Diagnostics.	Wortmannin	 (#W1628),	 Forskolin	 (#F6886)	 and	 Isoproterenol	 (#I6504)	
were	all	supplied	from	Sigma-Aldrich	(Dorset,	UK).	EGF	(#AF100-15),	TGFα	(#100-16A)	
were	purchased	from	Peprotech	(London,	UK)	and	EGF-AlexaFluor555	(#E35350)	was	
from	 Fisher	 Scientific.	 SAR405	 (#AOB6007)	 came	 from	 Aobious	 (MA,	 USA),	 Dyngo	
(#ab120689)	was	from	Abcam	(Cambridge,	UK)	and	IBMX	(#410957)	was	bought	from	

























Generation	of	 PtdIns(3)P	was	 inhibited	with	 either	 a	 15-minute	 treatment	of	 1µM	
Wortmannin	 or	 a	 2	 hour	 treatment	 with	 1µM	 SAR405.	 Dynamin	 inhibition	 was	
achieved	from	a	15-minute	pre-treatment	with	30µM	Dyngo.	The	same	concentration	
of	Dyngo	was	maintained	for	the	duration	of	the	experiment.	β-adrenergic	receptors	












(Paisley,	 UK).	 Rosetta™	 (DE3)	 competent	 cells	 (#70954)	 were	 bought	 from	Merck	
Millipore.	 Miniprep	 (#27106),	 HiSpeed	 Midiprep	 (#12643)	 and	 HiSpeed	 Maxiprep	
	 50	
(#12663),	 Gel	 extraction	 (#28704)	 kits	 and	 RNAase-free	DNAase	 (#79254)	were	 all	





Kit	 (#450031),	 pEF5/FRT/V5	 Directional	 TOPO™	 Cloning	 Kit	 (#K603501),	 TOP10	
competent	 cells	 (#C404003),	 One	 Shot®	 ccdB	 Survival™	 2	 T1R	 Competent	 Cells	
(#A10460)	 and	 Snakeskin®	 pleated	 dialysis	 tubing	 (3,500MWCO)	 (#68035)	 were	
bought	from	Fisher	Scientific	(Loughborough,	UK).	Gateway™	BP	Clonase™	II	Enzyme	
mix	 (#11789020)	 and	 Gateway™	 LR	 Clonase™	 II	 Enzyme	 mix	 (#11791020)	 were	
purchased	 from	 Life	 Technologies	 (Paisley,	 UK).	 Isopropyl	 β-D-1-
thiogalactopyranoside	(IPTG)	(#MB1008)	was	from	Melford	biolaboratories	(Suffolk,	
UK).	 Ethidium	 Bromide	 (EtBr)	 (#E1510),	 Lysozyme	 (#L6876)	 and	 Imidazole	 (#I202-
100G)	were	all	from	Sigma-Aldrich	(Dorset,	UK).	5ml	HisTrap	HP	column	(#17524801)	
and	 AKTA	 chromatography	 system	 are	 both	 from	 GE	 Healthcare	 Life	 Sciences	
(Buckinghamshire,	UK).	 pcDNA-APEX2-NES	 (#49386)	 (Lam,	Martell	 et	 al.	 2015)	 and	
pCSDEST-APEX2-GBP	 (#67651)	 (Ariotti,	 Hall	 et	 al.	 2015)	 were	 purchased	 from	
Addgene.	pcDNA3.1-AKAR4-NES	and	pcDNA3.1-ICUE3	plasmids	were	a	gift	from	Oliver	

















DG-ICUE3-3231F	 GGGAGGTACCTGAGGATCTATGG	 23	 64.2	 56%	
DG-ICUE3-3253R	 CCATAGATCCTCAGGTACCTCCC	 23	 64.2	 56%	
DG-ICUE3-2217F	 TGTTGTCAACCCACAGGAAG	 20	 57.3	 50%	
DG-AKAR4-1107F	 ACTAGGAGAAGACGGTAACC	 20	 57.3	 50%	


































A	 two-step	 PCR	was	 also	 used	 to	 create	 an	APEX2	 destination	 vector	 for	Gateway	









Finally,	 PCR	 was	 used	 to	 add	 FRT	 sites	 to	 the	 APEX2	 tagged	 HRS	 constructs	 from	
pcEXP221-APEX2-HRS	 and	 pcEXP221-APEX2-YYFF	 vectors,	 along	 with	 a	 cytosolic	
version	 of	 the	 enzyme	 from	 pcDNA3-APEX2-NES,	 to	 generate	 Flp-In	 compatible	
vectors.	 Examples	of	 the	PCR	 reactions	 and	 temperature	 cycles	used	are	 shown	 in	
tables	2.2	and	2.3	respectively.	
	
		 FFYVE	 Control	 	
Water	 Up	to	38.5µl	 38.5μl	 	
Plasmid	 -μl	 0μl	 (50ng)	




dNTPs	 0.5μl	 0.5μl	 	
HS	pfu	ultra	 1μl	 1μl	 	
Total	 50μl	 50μl	 	
	
Stage	 No.	Cycles	 Temp	 Duration	
1	 1	 95	 2	mins	
		 	 95	 30	sec	
2	 30	 55	 30	sec	
		 	 68	 1	min/kb	
















































Generally,	 500ng	 of	 DNA	 was	 used	 for	 test	 digests	 and	 4-5µg	 was	 used	 when	






1mM	 Na2-EDTA)	 and	 heated	 in	 a	 microwave	 until	 the	 agarose	 was	 completely	
dissolved.	 Prepared	 agarose	 gels	 were	 typically	 0.8-1.0%	 agarose	 (w/v).	 Ethidium	
Bromide	 (EtBr)	 was	 then	 added	 to	 a	 final	 concentration	 of	 0.5µg/ml	 to	 allow	 for	
visualisation	by	UV	light.	The	agarose	was	then	poured	and	allowed	to	cool	at	room	
temperature.	Samples	were	mixed	with	6x	sample	buffer	and	loaded	alongside	100bp	












































The	 Supernatant	was	 removed	 and	 the	 remaining	 pellet	was	 flash	 frozen	 in	 liquid	
nitrogen	and	stored	at	-20°C	until	ready	to	be	lysed.		
	
Frozen	 pellets	were	 thawed	 on	 ice.	 The	 bacteria	were	 then	 lysed	 on	 ice	 in	 a	 lysis	







overnight	 in	 3,500	MWCO	dialysis	 tubing	 and	 dialysis	 buffer	 (25mM	HEPES	 pH7.2,	
150mM	NaCl,	0.5mM	DTT).	The	purified	protein	was	flash	frozen	in	liquid	nitrogen	and	






into	 a	 pEF5/FRT/V5	 TOPO	 vector	 to	 generate	 pEF5/FRT/V5-TOPO-APEX2-NES,	




















For	 Live-cell	 imaging,	 µ-Dish	 35mm	 (#81156)	was	 purchased	 from	Thistle	 scientific	
(Glasgow,	UK).	Hank’s	balanced	salt	solution	(HBSS)	(#14065-049)	and	HEPES	(#15630-
056)	 were	 purchased	 form	 Life	 technologies.	 4ʹ,6-diamidino-2-phenylindole	 (DAPI)	
stain	 (#D1306)	 was	 bought	 from	 Invitrogen	 (Paisley,	 UK).	 Mowiol	 (#475904)	 was	




dEYEmond	 Ultra	 3mm	 45°	 diamond	 knife	 (#A2013213)	 was	 bought	 from	 Scimed	
GmbH	 (Germany).	 3,3’-Diaminobenzidine	 (DAB)	 (#D5905),	 Ethanol	 (#270741),	









a	20-minute	 incubation	 in	50mM	ammonium	chloride	 (NH4Cl).	The	cells	were	 then	
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permeabilised	with	0.2%	Triton-X	100	 in	PBS	for	4	minutes	before	being	blocked	 in	
10%	 goat	 serum	 for	 30	 minutes.	 The	 coverslips	 were	 then	 incubated	 in	 primary	
antibody	in	5%	goat	serum	for	20	minutes,	and	then	washed	in	PBS	three	times	for	5	
minutes.	 The	 secondary	 antibody	 in	 5%	 goat	 serum	 was	 then	 incubated	 with	 the	
coverslips	for	20	minutes,	followed	by	another	three	washes	in	PBS	for	5	minutes.	The	
coverslips	were	then	rinsed	in	water	and	mounted	onto	Mowiol	with	or	without	the	





Target	 Species	 Source/Catalog	No.	 Incubation	conditions	
















Live	 cell	 experiments	 were	 performed	 with	 a	 3i	 Marianas	 spinning	 disk	 confocal	

















spinning	 disk	 confocal	microscope.	 For	 each	 image,	 three	 channels	were	 captured	
denoted	‘Donor’	(447-517nm	detection	range,	445nm	excitation),	‘Acceptor’	(515-569	
detection	 range,	 514nnm	 excitation)	 and	 ‘Transfer’	 (515-569nm	 detection	 range,	
445nm	excitation)	channels.	For	the	FRET	experiments,	three	fields	of	view	were	taken	
to	generate	an	average	 for	each	biological	 repeat.	The	 images	were	 then	analysed	
using	the	Slidebook	6	software	(3i).	For	endosomal	FRET	sensor	cell	lines,	a	laplacian	
filter	was	applied	to	the	acceptor	channel,	in	order	to	generate	an	endosomal	mask	
for	 analysis.	 The	 intensities	 were	 measured	 and	 background	 and	 bleed	 through	
corrected.	FRET	was	calculated	from	the	intensities	using	the	following	equation:	
	




























tetramethylchromane-2-carboxylic	 acid	 (Trolox)	 (#238813),	Ascorbic	 acid	 (#A-7631)	
and	mammalian	protease	 inhibitor	 (MPI)	 (#P8340)	were	all	purchased	 from	Sigma-
Aldrich	(Dorset,	UK).	PhosSTOP	Phosphatase	inhibitor	cocktail	tablets	(#4906845001)	
were	purchased	from	Roche	(Sussex,	UK).	Marvel	skimmed	milk	powder	was	obtained	
from	 Premier	 Brands,	 UK.	 Pierce	 660-nm	 protein	 assay	 reagent	 (#22662)	 and	
Streptavidin	magnetic	beads	 (#88817)	were	bought	 from	Life	 technologies	 (Paisley,	
UK).	NHS-activated	Sepharose	4	Fast	Flow	beads	(#17-0906-01),	Amersham	ECL	full	
range	 rainbow	 marker	 (#RPN800E)	 and	 Amersham	 Protran	 0.45µm	 nitrocellulose	
membrane	(#10600002)	were	purchased	from	GE	healthcare	(Buckinghamshire,	UK).	
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Biotin-phenol	 (#LS-3500-0250)	 was	 from	 Iris	 Biotech	 GMBH	 and	 Sodium	 Azide	










buffer	 (10mM	 Tris	 pH	 7.5,	 150mM	 NaCl,	 1%	 Triton-X	 100,	 0.1%	 SDS,	 1%	 sodium	
deoxycholate).	 Both	 NP-40	 and	 RIPA	 buffer	 were	 supplemented	 with	 mammalian	
protease	 inhibitor	 cocktail	 (MPI).	 For	 experiments	 looking	 at	 phosphorylation,	 a	






The	 protein	 concentration	 of	 cell	 lysates	 was	 measured	 using	 the	 Pierce	 660-nm	
protein	 assay	 reagent.	 Protein	 assays	 were	 carried	 out	 as	 per	 the	 manufactures	








cells	were	 ready	 to	harvest,	 the	cell	medium	was	exchanged	 for	 fresh	 full	medium	
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Immunoprecipitation	 with	 GFP-nanotrap	 cross-linked	 to	 sepharose	 beads	 was	
performed	 immediately	 after	 cell	 lysis	 to	 avoid	 losing	 potential	 interactions	 from	
freeze-thaw	 cycles.	 Prior	 to	 immunoprecipitation,	 GFP-nanotrap	 sepharose	 beads	
were	pre-washed	in	whichever	lysis	buffer	was	used	to	generate	the	cell	lysates.	With	










used	 to	generate	 lysates.	Unless	otherwise	stated,	 the	beads	were	added	 to	 lysate	
samples	 in	a	 ratio	of	360µg	of	protein	 lysate	 for	30µl	of	magnetic	beads.	For	Mass	
spectrometry	experiments,	2-3mg	of	lysate	was	typically	used	per	condition,	which	are	























For	 Western	 blotting,	 proteins	 were	 transferred	 from	 polyacrylamide	 gels	 onto	







temperature	 for	 1	 hour.	 The	 membrane	 was	 then	 incubated	 in	 primary	 antibody	
according	 to	 the	 conditions	 described	 in	 table	 2.6.	 Unused	 primary	 antibody	 was	
removed	by	 three	5-minute	washes	 in	PBS-T	or	TBS-T,	 followed	by	 incubation	with	
IRDye	 conjugate-secondary	 antibodies	 (LI-COR	 Biosciences)	 for	 1	 hour.	 The	
	 64	
membranes	 were	 washed	 as	 above	 and	 visualised	 on	 a	 LI-COR	 Odessey	 imaging	
system.	A	summary	of	the	antibodies	used	are	shown	in	tables	2.6	and	2.7.	
	





















Actin	 Rabbit	 Sigma	(#A2266)	 1:10,000,	5%	milk	in	PBS-T,	1	hr,	
RT	































labelled	 media	 (Lys,	 #L8662;	 Arg,	 #A-8094;	 Pro,	 #P5607;	 Lys4,	 #616192;	 Arg6,	
#643440;	Lys8,	#608041;	Arg10,	#609033)	and	Iodoacetamide	(IAA)	(#T-6125)	were	
purchased	 from	 Sigma-Aldrich,	 (Dorset,	 UK).	 Dithiothreitol	 (DTT)	 (#MB1015)	 was	
purchased	 from	Melford	 biolaboratories	 (Suffolk,	 UK).	 Coomassie	 stain	 (#46-5034)	
was	 obtained	 from	 Invitrogen.	 LoBind	 Eppendorf	 tubes	 (#022431081)	 are	 from	
Eppendorf	(Hamburg,	Germany).	HPLC	grade	water	(#23595328),	HPLC	grade	formic	






HeLa	 S3	 Flp-In	 cell	 lines	were	 cultured	 in	 either	 ‘Light’,	 ‘Medium’	 or	 ‘Heavy’	 SILAC	
medium	 for	 at	 least	 two	 weeks	 (6	 passages)	 prior	 to	 experimentation	 to	 ensure	
optimal	isotope	labelling.	SILAC	medium	was	made	up	of	DMEM	supplemented	with	
10%	 dialysed	 FBS	 and	 amino	 acids	 to	 generate	 the	 ‘Light’,	 ‘Medium’	 or	 ‘Heavy’	
labelling.	These	amino	acids	are:	‘Light’	(L-Lysine,	Lys-0;	L-Arginine,	Arg-0;	L-Proline,	











and	diced	 into	 small	 pieces	using	a	 stainless	 steel	blade.	 The	gel	pieces	were	 then	
transferred	 to	 LoBind	 Eppendorf	 tubes	 and	 de-stained	 using	 a	 solution	 of	 50mM	
ammonium	bicarbonate	and	50%	acetonitrile	(ACN)	for	10	minutes	at	37°C.	The	de-
staining	step	was	repeated	until	all	the	stain	was	removed	from	the	gel	pieces.	The	gel	
pieces	 were	 then	 dehydrated	 in	 100%	 ACN	 for	 5	 minutes.	 The	 supernatant	 was	
discarded	and	the	gel	pieces	were	placed	in	a	speed	vacuum	for	a	further	5	minutes.	
10mM	DTT	in	100mM	ammonium	bicarbonate	was	added	to	the	gel	pieces	in	order	to	
reduce	 the	 protein	 samples.	 The	 gel	 pieces	 were	 incubated	 at	 56°C	 for	 1	 hour,	
followed	by	a	30-minute	incubation	in	50mM	iodoacetamide	in	100mM	ammonium	
bicarbonate	 at	 room	 temperature.	 Band	 pieces	 were	 then	 washed	 with	 100mM	
ammonium	bicarbonate	 for	15	minutes,	before	being	dehydrated	again	with	100%	
ACN	for	5	minutes	and	5	minutes	in	a	speed	vacuum.	The	proteins	within	the	gel	pieces	









tube.	 The	 formic	 acid	 incubation	was	 repeated	 once	more	 before	 100%	 ACN	was	
added	to	the	gel	pieces	for	10	minutes.	The	supernatant	was	once	again	transferred	










trapping	 column	 (Waters)	 in	 0.1%	 formic	 acid	 at	 10-15µl/min.	 Peptides	were	 then	
resolved	 on	 a	 25cm	 x	 75µm	BEH-C18	 column	 (Waters)	 on	 an	 ACN	 gradient	 and	 a	
300nl/min	flow	rate.	Mass	spectrometry	spectra	(m/z	300-2000)	were	obtained	at	a	
resolution	 of	 30,000	 and	 collision	 energy	 at	 35%,	 30ms.	 The	 top	 five	 ions	 were	
subjected	to	MS/MS	in	the	linear	quadrapole	ion	trap.	All	spectra	were	acquired	using	
the	Xcalibur	 software	 (Thermo	Fisher).	MS	 spectra	were	 analysed	using	MaxQuant	
(version	 1.5.3.8)	 using	 default	 settings,	 with	 additional	 SILAC	 labelling	 and	 biotin	
variable	modification.	 	
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Chapter	 three:	 Analysis	 of	 the	 HRS	
interactome	 in	 response	 to	growth	 factor	
stimulation	
	
The	 purpose	 of	HRS	 phosphorylation	 in	 response	 to	 growth	 factor	 stimulation	 has	
remained	elusive,	despite	being	a	topic	that	has	been	studied	on	numerous	occasions	
(Urbé,	Mills	et	al.	2000,	Row,	Clague	et	al.	2005,	Stern,	Visser	Smit	et	al.	2007,	Meijer,	
van	 Rotterdam	 et	 al.	 2012).	 HRS	 is	 highly	 phosphorylated	 in	 response	 to	 EGF	
stimulation	(Bache,	Raiborg	et	al.	2002,	Omerovic,	Hammond	et	al.	2012),	but	previous	












by	 performing	 immunoprecipitation	 (IP)	 using	 a	 polyclonal	 anti-GFP	 antibody	 with	
SILAC	labelled	cells	and	analysed	by	mass	spectrometry.		
	




G-proteins	 enriched	 in	 the	 EGF	 stimulated	 condition	 compared	 to	 the	 starved	
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antibody.	One	alternative,	 is	 to	use	the	GFP-nanotrap.	This	 is	a	 ‘nanobody’	derived	
from	the	hypervariable	region	of	a	Llama	antibody	(Rothbauer,	Zolghadr	et	al.	2008,	
Beghein	and	Gettemans	2017).	Antibodies	from	Camelidae	species	are	comprised	of	a	
single	 amino	 acid	 chain,	 in	 comparison	 to	 the	 two	 heavy	 and	 two	 light	 chains	 of	









HRS	 have	 only	 identified	 a	 few	 strong	 interactors,	 namely	 STAM1/2	 and	 Eps15	
(Roxrud,	Raiborg	et	al.	2008,	Huttlin,	Ting	et	al.	2015).	However,	it	is	known	that	HRS	
interacts	 with	 many	 more	 proteins,	 for	 example,	 through	 Yeast	 two	 hybrid	 (Y2H)	
experiments,	HRS	has	been	shown	to	bind	to	TSG101	(Pornillos,	Higginson	et	al.	2003).	
HRS	also	contains	a	ubiquitin	interacting	motif	and	is	important	for	the	trafficking	of	
ubiquitylated	 receptors,	 yet	 no	 receptors	 have	 been	 shown	 to	 bind	 to	 HRS	 by	






is	 used	 in	 proximity-labelling	 of	 proteins	 (Hwang	 and	 Espenshade	 2016).	 The	
advantage	of	using	this	enzyme	over	other	enzymes	used	for	proximity-labelling,	such	
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The	primary	objective	of	 this	chapter	was	 to	 investigate	 the	potential	difference	 in	
interacting	 partners	 between	 wild	 type	 HRS	 and	 the	 tyrosine	 point	 mutant	 under	
conditions	 of	 EGF	 stimulation,	 in	 order	 to	 assess	 the	 role	 of	 phosphorylation	 at	







I	 began	 by	 purifying	 the	 GFP-nanotrap	 in	 order	 to	 conjugate	 the	 nanobody	 to	
sepharose	beads.	The	GFP-nanotrap	plasmid	was	introduced	into	E.	coli	and	induced	
with	 IPTG.	After	 the	 cells	were	 lysed	by	 sonication,	 the	GFP-nanotrap	was	purified	
using	an	imidazole	gradient	on	a	His-Trap	column.	The	purification	of	the	nanobody	is	
shown	 in	 Figure	3.1.	A	 single	 large	peak	 is	 seen	on	 the	UV	 trace	 (blue	 line)	 as	 the	






















IP,	 with	 varying	 amounts	 of	 the	 protein	 lysate	 added	 to	 10µl	 of	 sepharose	 beads	













line)	 taken	 during	 the	 elution	 of	 the	 GFP-nanotrap	 off	 a	 His-Trap	 column	 with	
increasing	 concentrations	 of	 imidazole	 (green	 line).	 Red	 ticks	 represent	 the	
collected	fractions.	(B)	SDS-PAGE	of	the	fractions	indicated	by	the	two	larger	red	

















endogenous	 levels.	As	previously	mentioned,	over-expression	of	HRS	 can	 lead	 to	a	
dominant	negative	phenotype	in	the	normal	trafficking	and	degradation	of	receptors.	
The	levels	of	HRS	were	assessed	in	all	the	cell	lines	by	western	blotting.	The	GFP	tag	











cell	 lines,	 with	 peak	 phosphorylation	 occurring	 at	 8	 minutes.	 The	 signal	 then	








Further	 optimisation	 was	 undertaken	 for	 the	 following	 experiments.	 The	
concentration	of	EGF	was	titrated	to	ensure	a	high	enough	concentration	was	being	







stably	 expressing	GFP-tagged	 constructs	 co-stained	with	 an	 anti-EEA1	 antibody.	
Scale	bar	=	10µm	(B)	Western	blot	assessing	the	relative	levels	of	GFP-tagged	HRS	
constructs	compared	to	endogenous	levels.	Values	normalised	to	HRS	levels	of	GFP	
control.	 N	 =	 3.	 Error	 bars	 represent	 standard	 deviation.	 One-way	 ANOVA	 with	
Tukey’s	multiple	comparisons	test,	*	P	<	0.01,	**	P	<	0.0001.	(C&D)	HeLa	S3	GFP	
Flp-In	cells	were	serum	starved	for	6	hours	and	then	(C)	stimulated	with	20ng/ml	





















and	 the	 ribosomal	 protein,	 RPL14.	 Apart	 from	 these	 well-established	 interacting	
proteins,	no	other	proteins	(except	RPL14)	showed	any	significant	enrichment	outside	





















to	 be	 reliably	 detected	 by	 traditional	 IP	 techniques.	 As	 a	 result,	 proximity-ligation	
Figure	 3.3	 GFP-HRS	 interactome	 in	 EGF	 stimulated	 HeLa	 S3	 Flp-In	 cells.	 (A)	
Workflow	of	the	SILAC	experiment	using	the	stable	GFP	cell	lines.	In	gel	digest	was	
carried	 out	 on	 the	 samples	 prior	 to	 analysis	 with	 LC-MS/MS.	 Log2	 transformed	
ratios	plotted	against	Log10	transformed	intensities	for	(B)	GFP-HRS	versus	GFP,	(C)	



















Using	 this	 system	 for	 these	 experiments	 also	 offers	 another	 benefit	 over	 the	
traditional	 IP	 methodology.	 As	 labelling	 with	 biotin	 occurs	 prior	 to	 cell	 lysis,	 the	
samples	 can	 be	 combined	 prior	 to	 biotin-streptavidin	 IP	 (Figure	 3.4(C)).	 This	 will	
reduce	 the	 variation	 that	 may	 be	 introduced	 between	 samples	 when	 they	 are	










with	 20ng/ml	 EGF	 following	 a	 6-hour	 serum	 starvation	 and	 30-minute	 pre-















are	 taken	 from	 all	 parts	 of	 the	 streptavidin	 IP.	 The	 Input	 and	 flow-through	 (first	




non-labelled	negative	 control.	After	 looking	at	 the	 total	protein,	 the	blot	was	 then	
probed	for	biotin	using	a	streptavidin	antibody.	Stronger	staining	can	be	seen	in	the	
positive	controls	compared	to	 the	negative	controls,	 suggesting	 that	 the	enzyme	 is	
effectively	 labelling	 proteins	 with	 biotin.	 The	 bound	 fraction	 shows	 a	 massively	








In	 GFP	 cell	 lines	 transfected	 with	 APEX2-nanotrap	 were	 incubated	 with	 biotin-
phenol.	Biotinylation	was	stimulated	in	the	cells	where	indicated	before	the	cells	









































with	 LC-MS/MS.	 Log2	 transformed	 ratios	 plotted	 against	 Log10	 transformed	
intensities	for	(B)	GFP-HRS	versus	GFP,	(C)	GFP-YYFF	versus	GFP	and	(D)	GFP-HRS	













Figure	 3.7	 intensity	 analysis	 of	 HRS	 interactome	 generated	 with	 APEX2-tagged	


















last	 approach.	 I	 decided	 to	 make	 cell	 lines	 using	 the	 same	 Flp-In	 system	 used	 to	
generate	the	GFP-tagged	cell	lines.	The	idea	is	that	all	of	the	APEX2	enzyme	will	now	
be	associated	with	HRS	as	 they	would	be	directly	 linked	 to	each	other.	This	would	




















































antibodies.	 Scale	 bar	 =	 10µm	 (B)	 Western	 blot	 assessing	 the	 relative	 levels	 of	
APEX2-tagged	HRS	 constructs	 compared	 to	 endogenous	 levels.	 (C)	 APEX2	 Flp-In	
cells	were	serum	starved	for	6	hours	and	then	stimulated	with	20ng/ml	EGF	for	the	







that	 far	 fewer	biotin-labelled	proteins	have	been	 identified	 compared	 to	using	 the	




identified	 as	 up	 regulated	 in	 both	 conditions	 (Figure	3.10(B)).	 These	 are:	 the	 tRNA	










use	as	an	 internal	control.	Despite	 the	APEX2	enzyme	being	directly	 linked	 to	HRS,	
neither	HRS	or	STAM	were	 identified	 in	the	dataset.	Furthermore,	the	collection	of	
heterotrimeric	G-proteins,	along	with	Rac1,	were	also	absent	from	this	dataset.	This	

















• Only	 strong,	 well	 established	 interaction	 partners	 were	 identified	 by	 mass	
spectrometry	from	the	traditional	GFP	IP	
• Over-expression	 of	 APEX2-nanotrap	 in	 the	 GFP	 cell	 lines	 lead	 to	 a	 high	
background	 signal,	 with	 predominantly	 abundant	 cytosolic	 proteins	 being	
identified.		
• Mass	spectrometry	analysis	of	biotin	labelled	proteins	from	the	APEX2	cell	lines	
identified	 proteins	 associated	 with	 range	 of	 biological	 processes.	 These	
include:	RNA	regulation,	components	of	the	ubiquitin	cascade	pathway	and	a	
couple	of	metabolic	enzymes.	







As	 mentioned	 in	 the	 introduction	 to	 this	 chapter,	 the	 transient	 nature	 of	 these	
potential	interactions	makes	them	very	difficult	to	measure.	Evident	by	the	initial	mass	





the	 visualisation	 of	 GFP-labelled	 proteins	 (Ariotti,	 Hall	 et	 al.	 2015).	 The	 enzyme	 is	
linked	to	the	anti-GFP	nanobody	and	introduced	into	cells	via	a	transient	transfection.	
The	 GFP-nanotrap	 localises	 APEX2	 to	 GFP-tagged	 proteins.	 This	 method	 has	 been	
successfully	employed	in	electron	microscopy	studies.	In	this	chapter,	I	attempted	to	









To	 overcome	 these	 caveats,	 the	 APEX2	 enzyme	 was	 tagged	 directly	 to	 HRS	 and	
expressed	the	construct	in	cells	using	the	Flp-In	system.	This	should	avoid	the	issue	of	





the	 expression	 of	 APEX2	 is	 too	 low	 in	 these	 cell	 lines	 to	 obtain	 reliable	 mass	
spectrometry	 data.	 The	 amount	 of	 material	 identified	 in	 the	 APEX	 cell	 line	 mass	

















suggests	 that	HRS	phosphorylation	 inhibits	 the	 interaction	between	HRS	and	 these	
enzymes.	 A	 study	 on	 CXCR4	 has	 shown	 that	 various	 components	 of	 the	 ESCRT	
machinery	mediate	the	CXCR4-induced	activation	of	Akt	(Verma	and	Marchese	2015).	
This	study	suggests	that	the	ESCRT	machinery	regulates	Akt	activity	by	mediating	the	







mutant	HRS	cell	 lines.	 Interestingly,	DTX3L	has	been	shown	to	 regulate	another	E3	
ligase	atrophin-1	 interacting	protein	4	 (AIP4),	 independently	 from	 its	own	E3	 ligase	
activity	 (Holleman	 and	 Marchese	 2014).	 This	 prevents	 AIP4	 from	 ubiquitylating	
components	 of	 ESCRT-0,	 thus	 promoting	 the	 degradation	 of	 the	 cytokine	 receptor	
CXCR4.	DTX3L	 is	recruited	to	endosomes	upon	CXCR4	activation	and	knockdown	of	




















down-regulated	 and	 the	 receptor	 reset	 before	 being	 recycled	 back	 to	 the	 plasma	
membrane.		
	




and	 thyroid	 stimulating	 hormone	 (TSH)	 receptor	 (Calebiro,	 Nikolaev	 et	 al.	 2009,	
Ferrandon,	Feinstein	et	al.	2009),	but	has	subsequently	been	shown	to	be	exhibited	in	
various	other	GPCRs	including	the	β2-adrenergic	receptor	(Irannejad,	Tomshine	et	al.	
2013).	 Furthermore,	 work	 with	 the	 β2-adrenergic	 receptor	 also	 showed	 that	 the	
prolonged	 endosomal	 signal	 was	 responsible	 for	 the	 transcriptional	 response	
(Tsvetanova	and	von	Zastrow	2014).		
	
Despite	 the	 increasing	evidence	 to	 support	 this	model,	no	direct	measurements	of	
endosomally	produced	cAMP	have	been	recorded.	Current	methods	have	looked	at	
differences	 in	 the	 global	 cAMP	 population	 after	 various	manipulations	 to	 receptor	






2004	 by	 sandwiching	 cyan	 and	 yellow	 fluorophores	 around	 a	 full	 length	 Epac1	












PKA	 becomes	 active,	 it	 phosphorylates	 the	 pseudo-substrate.	 The	 phosphorylation	













surface	 (Behnia	 and	 Munro	 2005).	 Early	 endosomes	 are	 in	 part	 identified	 by	 the	







numerous	endosomal	 proteins,	many	of	which	 are	 critical	 for	 endosomal	 function.	























PtdIns(3)P,	 then	 disruption	 to	 the	 generation	 of	 this	 phospholipid	 should	 cause	










of	 the	AKAR4	construct,	as	demonstrated	 in	 the	schematic	 in	Figure	4.3(A).	AKAR4	


















































was	 easily	 resolved	with	 further	 cloning,	 by	 reintroducing	 the	NES	 to	 the	CFP-only	






Figure	 4.5	 Re-introducing	 the	 NES	 on	 the	 CFP-only	 versions	 of	 the	 AKAR4	
constructs.	(A)	Schematic	diagram	depicted	the	loss	and	re-introductions	of	the	NES	




























literature	surrounding	Epac	 localisation.	Epac	 is	activated	 in	 the	presence	of	cAMP	
and,	in	turn,	leads	to	the	activation	of	Rap1,	a	Ras	super	family	member.	For	efficient	
activation	 of	 Rap1,	 Epac1	 requires	 the	 interaction	 of	 Ran	 and	Ran	 binding	 protein	









to	 create	 a	 new	 construct	which	will	 now	be	 termed	 ICUE4,	 demonstrated	by	 the	
schematic	in	Figure	4.7(A).	Though	this	did	not	completely	abolish	the	nuclear	staining	
seen	 with	 ICUE3-FF,	 it	 did	 effectively	 redistribute	 the	 construct.	 The	 ICUE4-FF	
construct	 displayed	 puncta	 in	 the	 cell	 periphery,	 which	 co-localised	 with	 EEA1.	
Furthermore,	these	peripheral	puncta,	but	not	the	nuclear	localisation,	disappeared	
following	 treatment	with	Wortmannin	 and	 SAR405	 (Figure	 4.7(B)).	 From	 this	 I	 can	
















unable	 to	 open	 up	 and	 remains	 in	 an	 always	 closed	 conformation.	 Further	





ICUE3	 biosensors	 was	 measured	 after	 treatment	 of	 the	 β2-adrenergic	 receptor	
agonist,	 isoproterenol.	 Treatment	 with	 isoproterenol	 causes	 an	 increase	 in	 cAMP	
levels.	The	cAMP	then	interacts	with	the	biosensor	and	allow	it	to	open	up,	as	long	as	
it	is	still	able	to	undergo	a	conformational	change.	This	should	lead	to	a	measurable	
decrease	 in	 FRET.	 The	 ICUE4	 still	 exhibited	 changes	 to	 the	 emission	 ratios	 of	 the	

















Figure	 4.8	 ICUE4	 construct	 still	 able	 to	 undergo	 a	 conformational	 change	 in	




















Furthermore,	 the	 cell	 lines	 would	 provide	 more	 consistent	 intensities	 of	 the	











clone	AK-3,	and	for	the	ICUE4	cell	 lines,	this	was	either	clone	IC-2	or	 IC-7.	 IC-7	was	
chosen	due	to	the	fact	that	IC-2	grew	at	a	very	slow	rate.	The	cell	lines	expressing	the	
endosomal	 version	of	 the	FRET	 sensors	need	 to	be	chosen	more	carefully.	 For	 the	
AKAR4-FF	cell	lines,	clones	AKF-3,	AKF-5,	AKF-9	and	AKF-10	gave	a	very	low	expression	
level.	These	cell	lines	would	be	difficult	to	get	FRET	measurements	from	and	so	were	























































































































In	 order	 to	 test	 whether	 the	 endosomal	 FRET	 biosensors	 were	 giving	 solely	 an	
endosomal	measurement	for	cAMP	and	PKA	activity,	a	dynamin	inhibitor	was	utilised	
to	 block	 endocytosis	 and	 see	 how	 this	 may	 affect	 endosomal	 and	 cytosolic	 FRET	
measurements	 after	 stimulation	 with	 the	 β2-adrenergic	 receptor	 agonist,	
isoproterenol.	 A	 Laplacian	 filter	 was	 applied	 to	 images	 of	 cells	 expressing	 the	
endosomal	 FRET	 sensor	 in	 order	 to	 solely	 measure	 endosomal	 cAMP	 and	 PKA	





not	be	any	change	 in	 this	measurement,	a	small	change	 like	 the	one	observed	can	
easily	 be	 explained	 by	 the	 dynamin	 inhibitor	 preventing	 the	 endosomal	 produced	
cAMP	from	being	generated.		
	










With	 the	 PKA	 sensor,	 no	 significant	 difference	 is	 seen	 when	 the	 cytosolic	 AKAR4	
expressing	 cell	 line	 is	 treated	with	 the	dynamin	 inhibitor,	Dyngo,	 compared	 to	 the	























regions	 of	 the	 binary	 mask	 image	 appeared	 to	 stand	 out	 (highlighted	 by	 white	
arrowheads).	Some	of	these	regions	matched	up	with	the	endosomes	indicated	by	the	
















• The	FYVE	domain	was	 sufficient	by	 itself	 to	 localise	 the	AKAR4	construct	 to	
endosomes.	
• Additional	 modifications	 were	 required	 to	 localise	 the	 ICUE3	 construct	 to	
endosomes,	resulting	in	the	generation	of	the	ICUE4	construct.	
• The	 FRET	 biosensors	 localised	 to	 endosomes	 were	 unable	 to	 effectively	
distinguish	endosomally	derived	cAMP	generation	or	PKA	signalling.		
	


















that	 could	 reliably	 differentiate	 PKA	 activity	 or	 cAMP	 produced	 specifically	 at	 the	
endosome	(Figures	4.11	and	4.12).	The	development	of	such	tools,	however,	may	be	
a	 challenging	 endeavour	 due	 to	 the	 nature	 of	 the	 molecules	 being	 measured,	
particularly	 with	 regards	 to	 cAMP.	 cAMP	 is	 a	 small,	 diffusible	 second	 messenger	
molecule,	and	as	a	result	could	be	too	diffusible	to	spatially	differentiate	the	various	
sub-populations.	 Discrete	 microdomains	 have	 been	 well	 established	 for	 Ca2+	
signalling.	However,	 the	diffusion	 rate	of	Ca2+	 is	 approximately	10x	 lower	 than	 the	
diffusion	rate	of	cAMP	(50µm2s-1	opposed	to	500µm2s-1)	 (Zaccolo,	Magalhaes	et	al.	
2002).	This	would	explain	why	 ICUE4-FF	would	have	 similar	 kinetics	 in	 response	 to	












current	 endosomal	 AKAR4	 biosensor.	 The	 cell	 lines	 expressing	 the	 biosensor	 still	
displayed	a	relatively	large	cytosolic	background.	Further	work	may	be	able	to	reduce	
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this	 background	 and	 ultimately	 improve	 the	 signal-to-noise	 ratio.	 Expressing	 the	
biosensor	 in	 cells	 using	 a	 Flp-In	 system	 that	 allows	 for	 inducible	 expression	 may	
provide	more	stringent	control	over	the	expression	of	the	sensor	in	order	to	provide	
a	better	signal	for	FRET	measurements.	An	additional	approach	could	be	to	improve	
the	 affinity	 of	 the	 FRET	 sensor	 for	 endosomes.	 The	 FYVE	 domain	 of	 HRS	 alone	 is	















Conventionally,	 it	 is	 believed	 that	 the	 function	 of	 HRS	 is	 to	 corral	 ubiquitylated	




















downstream	 of	 EGFR	 activation,	 the	 dynamics	 of	 this	 relationship	 between	 the	
receptor	 and	 the	 HRS/WASH	 axis	 is	 currently	 unknown	 (MacDonald,	 Brown	 et	 al.	


















many	 proteins	 localise	 to	 endosomes	 through	 interactions	 with	 PtdIns(3)P.	 Over-
expression	of	a	FYVE	domain	containing	protein	leads	to	sequestration	of	PtdIns(3)P,	
changing	the	stoichiometry	of	endosomal	proteins.	As	these	cells	express	GFP-tagged	






























After	 seeing	 the	 number	 of	 HRS	 positive	 endosomes	 increase	 in	 response	 to	 EGF	
stimulation,	I	decided	to	see	if	there	might	be	any	difference	with	the	phosphorylation	
mutant	HRS	cell	line.	This	cell	line	has	two	tyrosine	residues,	Y329	and	Y334,	mutated	



















5.3(A)).	 As	 seen	 before,	 the	 number	 of	 HRS	 positive	 endosomes	 increased	 with	
stimulation	of	EGF.	With	the	addition	of	Transferrin,	however,	there	was	no	increase	
in	the	number	of	HRS	positive	endosomes.	Interestingly,	there	was	actually	a	gradual	
decrease	 in	 the	 number	 HRS	 positive	 endosomes	 over	 the	 time,	 resulting	 in	
Figure	5.2	Response	of	wild	type	and	mutant	HRS	to	EGF	stimulation.	(A)	GFP-HRS	






approximately	 half	 the	 number	 of	 puncta	 after	 10	 minutes.	 This	 is	 likely	 due	 to	
















the	 PI-3-kinase,	 VPS34,	 in	 order	 to	 increase	 the	 amount	 of	 PtdIns(3)P	 positive	
endosomes.	To	assess	this,	HeLa	cells	were	transfected	with	the	endosomal	marker,	
GFP-FENSFYVE	 (Figure	5.3(B)).	 The	 FYVE	domain	 from	FENS	 is	 sufficient	 enough	 to	
localise	 to	 PtdIns(3)P	 by	 itself,	 enabling	 it	 to	 act	 as	 a	marker	 for	 early	 endosomes	
(Ridley,	 Ktistakis	 et	 al.	 2001).	 The	 GFP-FF	 positive	 endosomes	 showed	 no	 distinct	
increase	in	the	number	of	endosomes	in	response	to	EGF.	There	does	appear	to	be	a	
slight	gradual	 increase	over	time,	however	this	 is	 insignificant	 in	comparison	to	the	
increase	in	HRS	positive	endosomes.	This	suggests	HRS	is	being	specifically	recruited	
























































GFP-HRS	 expressing	 HeLa	 cells	 after	 stimulation	 with	 20ng/ml	 EGF.	 Live-cell	
imaging	 took	 place	 immediately	 after	 stimulation.	 Scale	 bar	 =	 10µm.	 (B)	 The	
number	 of	HRS	 and	WASH	positive	 endosomes	with	 in	 the	 cells,	 displayed	 as	 a	






Different	 EGFR	 ligands	 have	 different	 effects	 on	 the	 trafficking	 of	 the	 receptor	 in	
response	to	stimulation	(Roepstorff,	Grandal	et	al.	2009).	EGF,	for	example,	leads	to	a	

































positive	 endosomes,	 increasing	 by	 approximately	 25%	 (Figure	 5.7),	 however	 this	
difference	 did	 not	 reach	 statistical	 significance.	 The	 peak	 number	 of	 positive	



















Despite	experiencing	trouble	with	 the	APEX2-HRS	cell	 line	 for	mass	spectrometry,	 I	
decided	to	see	if	I	they	could	be	used	for	electron	microscopy	(EM).	The	APEX2	enzyme	




APEX2-HRS	 cells	 were	 incubated	 with	 DAB	 prior	 to	 fixation.	 The	 cells	 were	 then	
incubated	with	H2O2	 and	 prepared	 for	 EM.	 Figure	 5.8	 shows	multiple	 examples	 of	
APEX2-HRS	staining	on	endosomes.	The	DAB	staining	appears	to	localise	to	a	distinct	
microdomain	 on	 the	 endosomes	 (arrowheads).	 The	 membrane	 within	 this	 region	
appears	flatter	than	the	rest	of	the	endosome.	These	regions	show	the	morphological	
characteristics	of	the	flat	clathrin	coat	present	on	endosomes	(Futter,	Gibson	et	al.	








A	 recent	 paper	 published	 at	 the	 end	 of	 experimentation,	 described	 waves	 of	
recruitment	of	various	components	of	 the	ESCRT	machinery	 (Wenzel,	Schultz	et	al.	
2018).	 By	 analysing	 individual	 endosomes,	 they	 identified	 concerted	 waves	 in	 the	
fluorescence	 intensity	 of	 HRS,	 TSG101	 and	 various	 CHMPs	 in	 response	 to	 EGF	
stimulation.	Analysis	of	the	experiments	described	in	this	chapter	have	focused	on	the	
population	 of	 HRS	 positive	 endosomes	 as	 a	 whole	 and	 not	 at	 an	 individual	 level.	





to	 demonstrate	 these	 waves	 of	 recruitment	 (Figure	 5.4(B)),	 with	 only	 established	
endosomes	displaying	this	characteristic.		




















stimulation.	 This	 has	 previously	 been	 difficult	 to	 study	 due	 to	 the	 fact	 that	
overexpression	of	HRS	 leads	to	a	dominant	negative	effect	on	endosomal	 function.	
Here,	 I	 used	HeLa	 cells	which	 are	 stably	 expressing	 either	wild	 type	GFP-HRS	 or	 a	
phosphorylation	mutant	GFP-HRS	(YYFF).	These	proteins	were	 introduced	using	the	
Flp-In	system,	generating	isogenic	cell	lines	which	express	the	tagged	proteins	at	near	
endogenous	 levels.	 These	 cells	 have	 allowed	 me	 to	 study	 the	 dynamics	 of	 HRS	
recruitment	without	disruption	to	endosome	morphology	or	function.		








after	EGF	stimulation.	They	also	 report	a	decrease	 in	 the	 immobile	 fraction	of	HRS	
after	performing	FRAP	experiments.	These	findings	fit	 in	with	previous	finding	from	
my	laboratory	that	show	a	greater	proportion	of	phosphorylated	HRS	in	the	cytosol	
than	 on	 endosomes	 (Urbé,	 Mills	 et	 al.	 2000).	 However,	 this	 transient	 drop	 in	
endosomal	HRS	fluorescence	is	a	finding	which	I	have	been	unable	to	observe	in	the	
experiments	 described	 above.	 Furthermore,	 FRAP	 experiments	 performed	 by	 a	
colleague	 found	the	opposite	effect	on	 the	 immobile	 fraction	of	HRS,	observing	an	
increase	in	the	immobile	fraction	after	stimulation	with	EGF	(Macdonald,	unpublished	
results).	The	results	did	show	that	the	HRS	phosphorylation	mutant	had	no	change	to	




al.,	 despite	 the	 fact	 that	 both	 studies	 use	 stably	 expressing	 cell	 lines	 to	 study	HRS	










lentivirus-generated	 cell	 lines	 expressing	 various	 ESCRT	 components	 tagged	 to	
fluorescent	markers	(Wenzel,	Schultz	et	al.	2018).	This	resulted	in	the	expression	of	
mCherry-HRS	at	near	endogenous	levels.	Importantly,	this	study	doesn’t	manipulate	



























the	 recruitment	 of	 the	HRS	 binding	 partner,	 Eps15	 (Gucwa	 and	 Brown	 2014).	 It	 is	
possible	that	these	two	proteins	are	recruited	to	endosomes	 in	a	similar	fashion	to	
















reveal	 distinct	 microdomains	 that	 resemble,	 flat	 clathrin	 coated	 domains	 (Futter,	
Gibson	 et	 al.	 1998,	 Sachse,	 Urbé	 et	 al.	 2002).	 These	 domains	 can	 be	 difficult	 to	
visualise.	HRS	appears	to	be	confined	to	microdomains	on	flat	regions	of	endosomes.	
















for	 the	 study	 of	 mitochondria	 and	 has	 been	 very	 effective	 at	 labelling	 the	 whole	




cytosolic	 facing	membrane	 of	 organelles	 (Hung,	 Zou	 et	 al.	 2014,	 Hung,	 Lam	 et	 al.	
2017).	The	first	example	of	this	kind	of	study	was	for	the	 investigation	of	signalling	
events	 in	primary	 cilia	 (Mick,	 Rodrigues	 et	 al.	 2015).	Access	 to	 the	primary	 cilia	 is,	





show	 that	 the	 enzyme	 can	 also	 be	 used	 to	 examine	 a	 specific	 protein	 network	
(Lobingier,	Huttenhain	et	al.	2017).	The	authors	tagged	the	β-adrenergic	receptor	with	
APEX2	to	examine	the	proteins	which	engage	with	the	receptor	as	it	traffics	from	the	
plasma	membrane	 to	 the	 endosome.	 They	 targeted	 the	 APEX2	 enzyme	 to	 various	
compartments	to	use	as	 ‘compartment	references’	 in	order	to	spatially	 resolve	the	
specific	protein	network	from	what	they	term	as	‘bystanders’,	i.e.	proteins	which	are	
present	 in	 close	 proximity	 to	 the	 protein	 network	 but	 are	 not	 directly	 involved	
(Lobingier,	 Huttenhain	 et	 al.	 2017).	 This	 approach	works	well	 for	 the	 β-adrenergic	
receptor,	 since	 it	 is	 a	 transmembrane	 receptor,	 and	 therefore	 only	 exists	 on	 lipid	
membranes.	 The	 additional	 challenge	 faced	 when	 applying	 these	 approaches	 to	
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proximity	ligation	of	HRS	interactors,	is	that	the	membrane	interaction	of	HRS	is	very	




















phosphorylated	 in	 response	 to	 EGF	 stimulation	 (Omerovic,	Hammond	et	 al.	 2012).	
Biotin-phenol	radicals	generated	by	APEX2	preferentially	bind	to	tyrosine	(Hung,	Zou	
et	al.	2014).	This	 raises	 the	question	of	whether	tyrosine	phosphorylation	prevents	
































exhibiting	 auto-inhibition	 of	 itself	 through	 the	 UIM	 binding	 to	 its	 own	 ubiquitin	







In	 the	 work	 presented	 in	 chapter	 five,	 I	 show	 that	 HRS	 is	 recruited	 directly	 to	


















me	 to	 suggest	 that	 tyrosine	 residues	 329	 and	 334	 may	 be	 involved	 in	 recruiting	
recycling	machinery	to	endosomes.	Endosomal	recruitment	of	the	recycling	complex	
WASH	 is	mediated	 in	 part	 by	 HRS,	 though	 the	mechanism	 by	which	 this	 occurs	 is	
unclear	(MacDonald,	Brown	et	al.	2018).		
	
Recycling	 of	 the	 EGFR	 when	 stimulated	 with	 TGFα	 is	 believed	 to	 be	 due	 to	 the	
dissociation	rate	between	the	ligand	and	the	receptor.	TGFα	dissociates	from	the	EGFR	
at	a	less	acidic	pH	than	EGF	and	so	is	uncoupled	from	the	EGFR	at	the	early	endosome	
(Ebner	 and	 Derynck	 1991).	 This	 was	 thought	 to	 encourage	 the	 recycling	 of	 the	
receptor	rather	than	its	degradation.	The	data	described	in	the	present	study	suggests	







central	 role	 in	 endosomal	 sorting	 and	 is	 ‘primed’	 to	 respond	 depending	 on	 the	
incoming	cargo	(Figure	6.1).	HRS	is	primed	based	on	the	phosphorylation	and	ubiquitin	
code,	 determined	 by	 upstream	 signalling	 molecules.	 Receptors	 that	 are	 primarily	
degraded,	 phosphorylate	 HRS	 in	 a	 way	 that	 primes	 it	 for	 degradation	 processes,	
encouraging	HRS	 to	 recruit	 the	 degradation	machinery.	 Conversely,	 receptors	 that	
need	 recycling	 will	 lead	 to	 a	 different	 pattern	 of	 phosphorylation	 and	 ubiquitin	





Figure	 6.1	 A	 working	 model	 for	 HRS	 ‘priming’.	 The	 activated	 receptors	 being	
trafficked	 to	 the	 endosomes	 ‘primes’	 HRS	 by	 inducing	 a	 particular	 pattern	 of	
phosphorylation	 (red	 circles)	 and	 ubiquitin	 (purple	 circles)	 modifications.	 This	
profile	of	modifications	then	determines	the	response	of	HRS	to	the	incoming	cargo	








undertaken.	 Further	 work	 is,	 however,	 required	 in	 order	 to	 improve	 upon	 those	
generated	here.	Measurements	of	cAMP	at	endosomes	may	be	a	more	challenging	
endeavour	due	to	the	diffusion	rate	of	the	second	messenger.	Regulation	of	PKA	is	







Generation	 of	 the	 APEX2-HRS	 cell	 lines	 using	 the	method	 described	was	 the	most	
applicable	 in	 terms	 of	 HRS	 biology.	 It	 led	 to	 the	 expression	 of	 the	 APEX2-HRS	







As	 HRS	 is	 heavily	 tyrosine	 phosphorylated	 in	 response	 to	 many	 growth	 factors,	
labelling	with	biotin	phenol	by	APEX2	may	 lead	to	the	poor	 labelling	of	HRS.	 In	this	
vein,	it	may	be	more	appropriate	to	use	the	turboID	enzyme	for	proximity	labelling	of	
HRS	 interactors,	 as	 this	 enzyme	 leads	 to	 the	 labelling	 of	 lysine	 residues	 instead	 of	
tyrosine.	The	reduced	labelling	time	of	this	enzyme	over	its	predecessors,	may	allow	



















acute	 stimulation	 with	 this	 ligand	 also	 had	 an	 impact	 on	 HRS	 recruitment.	
Furthermore,	DTX3L	was	 identified	 in	the	mass	spectrometry	dataset,	which	was	 in	
the	 context	 of	 EGF	 stimulation.	 DTX3L	 is	 recruited	 to	 endosomes	 in	 response	 to	














phosphorylation	 profile	 of	 HRS	 has	 been	 observed	 with	 different	 growth	 factor	
receptors	(Row,	Clague	et	al.	2005,	Francavilla,	Papetti	et	al.	2016).	Tyrosine	residues	
329	and	334	were	used	in	this	study	due	to	their	identification	by	Urbé	et	al.	(Urbé,	





The	 identification	 of	 the	 E3	 ligase	 DTX3L	 highlights	 the	 potential	 role	 of	 HRS	
ubiquitylation	in	ligand-induced	HRS	recruitment.	Manipulation	to	the	ubiquitylation	
of	HRS	is	likely	to	alter	the	dynamics	of	its	recruitment.	This	can	be	achieved	through	







The	 aim	 of	 the	 work	 described	 in	 this	 thesis,	 was	 to	 establish	 HRS	 as	 a	 signalling	
adaptor	involved	in	the	crosstalk	between	RTKs	and	GPCRS,	as	well	as	ascertain	the	
function	 of	 HRS	 phosphorylation.	 I	 was	 unable	 to	 confirm	 the	 EGF	 dependent	
interactions	of	HRS	with	the	collection	of	G-proteins	 found	 in	the	preliminary	work	







My	 work	 on	 FRET	 based	 biosensors	 for	 the	 measurements	 of	 endosomal	 cAMP	
production	and	endosomal	PKA	signalling	will	need	further	development.	The	purpose	










HRS	 in	 response	 to	 TGFα	 stimulation,	 but	 not	 with	 EGF	 stimulation.	 This	 provides	







stimulated	 with	 Isoproterenol.	 Pixel	 intensities	 derived	 from	 a	 binary	mask	 of	 the	
acceptor	channel.	
	
Supplementary	 movie	 2	 Pseudo	 colour	 movie	 of	 FRET	 from	 the	 same	 AKAR4-FF	






























Supplementary	 Figure	 3	 Plasmid	 map	 of	 pcDNA3.1-ICUE3	 vector.	 Plasmid	 map	
show	the	locations	of	the	restriction	sites	used	in	Supplementary	Figure	1.		
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Supplementary	Figure	4	Plasmid	map	of	pcDNA3.1-ICUE3-FFYVE	vector.	Plasmid	
map	show	the	locations	of	the	restriction	sites	used	in	Supplementary	Figure	1.		
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